BioCardia board adopts amended and restated bylaws for advance notice and technical updates

BioCardia, Inc.

Amended bylaws update advance notice procedures for director nominations and stockholder proposals.
Changes align with current SEC rules and recent amendments to the Delaware General Corporation Law.
Bylaws also include technical, modernizing, and clarifying changes effective April 30, 2023.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BioCardia, Inc.: Amended and restated bylaws to update advance notice procedures for director nominations and stockholder business proposals, align with SEC rules and Delaware law, and include technical changes (effective 2023-04-30).

Change: bylaw amendment
Effective: 2023-04-30

Exact text from the filing

On April 30, 2023, the board of directors (the “Board”) of BioCardia, Inc. (the “Company”), acting upon the recommendation of the Board’s Nominating and Corporate Governance Committee, approved and adopted amended and restated bylaws (the “Amended and Restated Bylaws”), which became effective immediately.

View on SEC.gov

Browse all governance changes →

BioCardia, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-011915

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.